(Q41614294)

5 October 2017

title

miRNA-155 modulates the malignant biological characteristics of NK/T-cell lymphoma cells by targeting FOXO3a gene (English)

1 reference

extranodal NK/T-cell lymphoma, nasal type

5 October 2017

main subject

1 reference

Wei-guo Ji

1

1 reference

5 October 2017

Xu-dong Zhang

2

1 reference

5 October 2017

Xiang-dong Sun

3

1 reference

5 October 2017

Xiang-qi Wang

4

1 reference

5 October 2017

Bao-ping Chang

5

1 reference

5 October 2017

Ming-zhi Zhang

6

1 reference

5 October 2017

publication date

6 December 2014

1 reference

Journal of Huazhong University of Science and Technology. Medical Sciences

5 October 2017

published in

1 reference

5 October 2017

volume

34

1 reference

5 October 2017

issue

6

1 reference

5 October 2017

page(s)

882-888

1 reference

https://scigraph.springernature.com/pub.10.1007/s11596-014-1368-z

5 October 2017

exact match

0 references

cites work

miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

The prognostic value of miR-21 and miR-155 in non-small-cell lung cancer: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

The role of microRNAs in breast cancer migration, invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

Expression of FoxO3a in clinical cases of malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1368-Z

10.1007/S11596-014-1368-Z

21 January 2018

Identifiers

DOI

1 reference

5 October 2017

1 reference